SterRx recalls epinephrine injections due to lack of sterility assurance. This medication, used for emergencies, may be contaminated. Affected products have specific NDC numbers and were sold in New York.
Lack of Assurance of Sterility
SterRx is recalling epinephrine injections that could be contaminated. This poses a risk of infection if used improperly. The recall affects specific products sold in New York.
The injections lack assurance of sterility, meaning they could contain harmful bacteria. If used, this could lead to infections, especially in critical medical situations.
People with prescriptions for epinephrine injections in New York. Those who have the specific NDC numbers listed are most at risk.
Check for the NDC number 70324-077-01 on the product label. Products were sold in New York starting January 2022 with specific batch codes.
Look for the NDC number 70324-077-01 on the injection label.
The recall states there is a lack of sterility assurance, so it is not safe to use.
The recall does not specify a remedy, so check with your healthcare provider for guidance.
Products were sold in New York starting January 2022 with specific batch codes.
We’ve drafted a message you can send SterRx to request your refund or repair — edit it as you like.
Subject: Recall D-0310-2022 — SterRx SterRx Hello, I own a SterRx that is covered by recall D-0310-2022 from SterRx. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
